All Categories
XBIRA 250MG

XBIRA 250MG

Abiraterone 250mg is a formulation of Zytiga & prednisone that is identified as a proven remedy to treat Metastatic castration-resistant prostate cancer as well as sensitive prostrate cancer. The recommended dose for this drug is 1,000mg for day & patients are advised to consume its tablet on an empty stomach.

Manufacture : Cipla Pharmaceuticals

Active Ingredient: ABIRATERONE 250MG

Packing : 120 TABLETS

Related Products

OXIPLAT 50

OXIPLAT 50

Manufacture : SUN PHARMACEUTICAL

Oxaliplatin is a unique formulation to combat advanced colon or rectal cancer, a

Erlocip 150

Erlocip 150

Manufacture : Cipla Pharmaceuticals

The Erlocip 150 tablets are used for the individuals who suffer from consistent

BDENZA

BDENZA

Manufacture : BDR PHARMACEUTICALS

Enzalutamide, sold under the brand name Bdenza, is a non-steroidal antiandrogen

Most Viewed

Blog

Blog2

Blog2

  • 08 Oct, 2018
  • Posted by
  • Admin

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et

Blog1

Blog1

  • 26 Oct, 2018
  • Posted by
  • Admin

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et

Blog

Blog

  • 09 Oct, 2018
  • Posted by
  • Admin

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et

FOLLOW US ON
© 2020 Universal Health Care and Suppliers. All Rights Reserved.